{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T17:28:59Z","timestamp":1785432539338,"version":"3.56.0"},"reference-count":213,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Harvard-wide Program on Antibiotic Resistance","award":["NIH AI083214"],"award-info":[{"award-number":["NIH AI083214"]}]},{"name":"Innovate2Impact Award","award":["Tufts CSTI GR1005708"],"award-info":[{"award-number":["Tufts CSTI GR1005708"]}]},{"DOI":"10.13039\/501100004431","name":"Fondation de France","doi-asserted-by":"publisher","award":["Engagement 00168190\/WB-2025-58291"],"award-info":[{"award-number":["Engagement 00168190\/WB-2025-58291"]}],"id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"publisher"}]},{"award":["Engagement 00168190\/WB-2025-58291"],"award-info":[{"award-number":["Engagement 00168190\/WB-2025-58291"]}],"id":[{"id":"https:\/\/ror.org\/02zkxjz73","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Severe bacterial keratitis and endophthalmitis are leading causes of corneal scarring, enucleation, and permanent vision loss, and are increasingly complicated by multidrug-resistant Gram-positive ocular pathogens. In the United States, according to the ARMOR surveillance program (2009\u20132020), methicillin resistance reached 45.9% of intraocular Staphylococcus aureus and 47.9% of coagulase-negative staphylococci (CoNS), with multidrug resistance exceeding 70% among methicillin-resistant intraocular isolates. While new antibiotics have been approved for systemic infections, vancomycin remains the standard of care for severe Gram-positive ocular infections. However, its ophthalmic use is constrained by limited ocular surface tolerability, physical incompatibility with intravitreal ceftazidime, and an association with hemorrhagic occlusive retinal vasculitis. To address this gap and further stimulate the development of next-generation targeted therapies in ophthalmology, this review focuses on current recommendations and new vancomycin alternative treatments for Gram-positive ocular infections in the antibiotic resistance era. This review details the current antimicrobial recommendations for the most frequent ocular infections, followed by the epidemiology and molecular mechanisms of resistance in S. aureus, CoNS, and S. pneumoniae. Finally, this review discusses new drugs that represent promising alternatives to vancomycin in ophthalmology.<\/jats:p>","DOI":"10.3390\/antibiotics15070710","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T10:48:28Z","timestamp":1784717308000},"page":"710","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Current Recommendations, Antibiotic Resistance, and Emerging Treatments for Gram-Positive Ocular Infections in the United States"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5329-2145","authenticated-orcid":false,"given":"In\u00e8s","family":"Fenniri","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, 243 Charles Street, Boston, MA 02114, USA"},{"name":"Infectious Disease Institute, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA 02114, USA"},{"name":"Department of Ophthalmology, Boston Children\u2019s Hospital, Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115, USA"},{"name":"Department of Ophthalmology, H\u00f4pital Edouard Herriot, Hospices Civils de Lyon, Universit\u00e9 Claude Bernard Lyon 1, 5 Place d\u2019Arsonval, 69003 Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Andr\u00e9","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, 243 Charles Street, Boston, MA 02114, USA"},{"name":"Infectious Disease Institute, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA 02114, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/01.inf.0000178066.24569.98","article-title":"Clinical and Bacterial Characteristics of Acute Bacterial Conjunctivitis in Children in the Antibiotic Resistance Era","volume":"24","author":"Buznach","year":"2005","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0002-9394(03)00896-1","article-title":"Endophthalmitis Isolates and Antibiotic Sensitivities: A 6-Year Review of Culture-Proven Cases","volume":"137","author":"Benz","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1136\/bjophthalmol-2020-316128","article-title":"12-Year Analysis of Incidence, Microbiological Profiles and in Vitro Antimicrobial Susceptibility of Infectious Keratitis: The Nottingham Infectious Keratitis Study","volume":"105","author":"Ting","year":"2021","journal-title":"Br. J. Ophthalmol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/ICL.0000000000000642","article-title":"The Prevalence of Bacteria, Fungi, Viruses, and Acanthamoeba from 3004 Cases of Keratitis, Endophthalmitis, and Conjunctivitis","volume":"46","author":"Kowalski","year":"2020","journal-title":"Eye Contact Lens"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S1726-4901(09)70284-9","article-title":"Preseptal and Orbital Cellulitis: A 10-Year Review of Hospitalized Patients","volume":"69","author":"Liu","year":"2006","journal-title":"J. Chin. Med. Assoc."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.ophtha.2007.10.011","article-title":"Infantile Orbital Cellulitis","volume":"115","author":"Miller","year":"2008","journal-title":"Ophthalmology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e566","DOI":"10.1542\/peds.2010-2117","article-title":"Microbiology and Antibiotic Management of Orbital Cellulitis","volume":"127","author":"Seltz","year":"2011","journal-title":"Pediatrics"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-0420.2007.01006.x","article-title":"Acute Bacterial Conjunctivitis","volume":"86","year":"2008","journal-title":"Acta Ophthalmol."},{"key":"ref_9","first-page":"0704","article-title":"Bacterial Conjunctivitis","volume":"2012","author":"Epling","year":"2012","journal-title":"BMJ Clin. Evid."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.survophthal.2018.12.003","article-title":"The Persistent Dilemma of Microbial Keratitis: Global Burden, Diagnosis, and Antimicrobial Resistance","volume":"64","author":"Ung","year":"2019","journal-title":"Surv. Ophthalmol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1136\/bjo.87.7.834","article-title":"Bacterial Keratitis: Predisposing Factors, Clinical and Microbiological Review of 300 Cases","volume":"87","author":"Bourcier","year":"2003","journal-title":"Br. J. Ophthalmol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.15.1.111-124.2002","article-title":"Bacterial Endophthalmitis: Epidemiology, Therapeutics, and Bacterium-Host Interactions","volume":"15","author":"Callegan","year":"2002","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ajo.2013.01.027","article-title":"Endophthalmitis Isolates and Antibiotic Susceptibilities: A 10-Year Review of Culture-Proven Cases","volume":"156","author":"Schimel","year":"2013","journal-title":"Am. J. Ophthalmol."},{"key":"ref_14","unstructured":"Danishyar, A., and Sergent, S.R. (2023). Orbital Cellulitis. StatPearls, StatPearls Publishing."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.ajo.2008.01.025","article-title":"Ocular TRUST: Nationwide Antimicrobial Susceptibility Patterns in Ocular Isolates","volume":"145","author":"Asbell","year":"2008","journal-title":"Am. J. Ophthalmol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1001\/jamaophthalmol.2020.0155","article-title":"Trends in Antibiotic Resistance Among Ocular Microorganisms in the United States From 2009 to 2018","volume":"138","author":"Asbell","year":"2020","journal-title":"JAMA Ophthalmol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jgar.2022.03.010","article-title":"Antibiotic Susceptibility of Bacterial Pathogens Isolated from the Aqueous and Vitreous Humour in the Antibiotic Resistance Monitoring in Ocular micRoorganisms (ARMOR) Surveillance Study: 2009\u20132020 Update","volume":"29","author":"Asbell","year":"2022","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Song, X., Xie, L., Tan, X., Wang, Z., Yang, Y., Yuan, Y., Deng, Y., Fu, S., Xu, J., and Sun, X. (2014). A Multi-Center, Cross-Sectional Study on the Burden of Infectious Keratitis in China. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0113843"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1136\/bjophthalmol-2016-310026","article-title":"Evolving Risk Factors and Antibiotic Sensitivity Patterns for Microbial Keratitis at a Large County Hospital","volume":"101","author":"Jin","year":"2017","journal-title":"Br. J. Ophthalmol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"28100","DOI":"10.1038\/srep28100","article-title":"Risk Factors for Endophthalmitis Requiring Evisceration or Enucleation","volume":"6","author":"Lu","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1586\/eop.10.52","article-title":"Severe Bacterial Endophthalmitis: Towards Improving Clinical Outcomes","volume":"5","author":"Novosad","year":"2010","journal-title":"Expert Rev. Ophthalmol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global Burden of Bacterial Antimicrobial Resistance in 2019: A Systematic Analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"ref_23","unstructured":"Clinical and Laboratory Standards Institute (2026). Performance Standards for Antimicrobial Susceptibility Testing, Clinical and Laboratory Standards Institute. [36th ed.]. CLSI Supplement M100."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"P87","DOI":"10.1016\/j.ophtha.2023.12.035","article-title":"Bacterial Keratitis Preferred Practice Pattern\u00ae","volume":"131","author":"Rhee","year":"2024","journal-title":"Ophthalmology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ophtha.2016.11.042","article-title":"Vancomycin-Associated Hemorrhagic Occlusive Retinal Vasculitis: Clinical Characteristics of 36 Eyes","volume":"124","author":"Witkin","year":"2017","journal-title":"Ophthalmology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/bjo.84.1.117a","article-title":"Vancomycin and Ceftazidime Incompatibility upon Intravitreal Injection","volume":"84","author":"Lifshitz","year":"2000","journal-title":"Br. J. Ophthalmol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3341\/kjo.2018.0080","article-title":"Precipitation of Vancomycin and Ceftazidime on Intravitreal Injection in Endophthalmitis Patients","volume":"33","author":"Noh","year":"2019","journal-title":"Korean J. Ophthalmol."},{"key":"ref_28","first-page":"126","article-title":"Comparing the Ocular Surface Effects of Topical Vancomycin and Linezolid for Treating Bacterial Keratitis","volume":"35","author":"Baykara","year":"2016","journal-title":"Cutan. Ocul. Toxicol."},{"key":"ref_29","first-page":"352","article-title":"Evaluation of the in Vitro Ocular Toxicity of the Fortified Antibiotic Eye Drops Prepared at the Hospital Pharmacy Departments","volume":"40","author":"Pardo","year":"2016","journal-title":"Farm. Hosp."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"106946","DOI":"10.1016\/j.ijantimicag.2023.106946","article-title":"Efficacy and Safety of Vancomycin for the Treatment of Staphylococcus aureus Bacteraemia: A Systematic Review and Meta-Analysis","volume":"62","author":"Zhang","year":"2023","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijporl.2019.02.037","article-title":"Recurrent Periorbital Cellulitis Associated with Rhinosinusitis in Children: Characteristics, Course of Disease, and Management Paradigm","volume":"121","author":"Tzelnick","year":"2019","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","article-title":"Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists","volume":"77","author":"Rybak","year":"2020","journal-title":"Am. J. Health Syst. Pharm."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Bradley, J.S., Nelson, J.D., Barnett, E.D., Cantey, J.B., Kimberlin, D.W., Palumbo, P.E., Sauberan, J., Smart, J.H., and Steinbach, W.J. (2023). 2023 Nelson\u2019s Pediatric Antimicrobial Therapy, American Academy of Pediatrics. [29th ed.].","DOI":"10.1542\/9781610025652"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11908-012-0238-8","article-title":"Dacryocystitis: Systematic Approach to Diagnosis and Therapy","volume":"14","author":"Sota","year":"2012","journal-title":"Curr. Infect. Dis. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"P134","DOI":"10.1016\/j.ophtha.2023.12.037","article-title":"Conjunctivitis Preferred Practice Pattern\u00ae","volume":"131","author":"Cheung","year":"2024","journal-title":"Ophthalmology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"372","DOI":"10.18502\/jovr.v15i3.7456","article-title":"Conjunctivitis: A Systematic Review","volume":"15","author":"Azari","year":"2020","journal-title":"J. Ophthalmic Vis. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1586\/14787210.3.1.131","article-title":"Ocular Bacterial Infections: Current and Future Treatment Options","volume":"3","author":"Kowalski","year":"2005","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.ophtha.2006.12.011","article-title":"Clinical Efficacy of Moxifloxacin in the Treatment of Bacterial Keratitis: A Randomized Clinical Trial","volume":"114","author":"Constantinou","year":"2007","journal-title":"Ophthalmology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/ICO.0000000000000664","article-title":"Gatifloxacin 0.3% Versus Fortified Tobramycin-Cefazolin in Treating Nonperforated Bacterial Corneal Ulcers: Randomized, Controlled Trial","volume":"35","author":"Sharma","year":"2016","journal-title":"Cornea"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.ophtha.2012.11.013","article-title":"Evaluation of Moxifloxacin 0.5% in Treatment of Nonperforated Bacterial Corneal Ulcers: A Randomized Controlled Trial","volume":"120","author":"Sharma","year":"2013","journal-title":"Ophthalmology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ajo.2005.08.081","article-title":"Comparison of Topical Gatifloxacin 0.3% and Ciprofloxacin 0.3% for the Treatment of Bacterial Keratitis","volume":"141","author":"Parmar","year":"2006","journal-title":"Am. J. Ophthalmol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1177\/112067211002000207","article-title":"In Vitro Susceptibility of Bacterial Keratitis Isolates to Fourth-Generation Fluoroquinolones","volume":"20","author":"Chawla","year":"2010","journal-title":"Eur. J. Ophthalmol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/ICO.0b013e3181ca2ba3","article-title":"Randomized Clinical Study for Comparative Evaluation of Fourth-Generation Fluoroquinolones with the Combination of Fortified Antibiotics in the Treatment of Bacterial Corneal Ulcers","volume":"29","author":"Shah","year":"2010","journal-title":"Cornea"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.2147\/OPTH.S23518","article-title":"Integrated Analysis of Three Bacterial Conjunctivitis Trials of Besifloxacin Ophthalmic Suspension, 0.6%: Microbiological Eradication Outcomes","volume":"5","author":"Morris","year":"2011","journal-title":"Clin. Ophthalmol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1097\/ICO.0b013e31819e34cb","article-title":"Efficacy of Besifloxacin in a Rabbit Model of Methicillin-Resistant Staphylococcus aureus Keratitis","volume":"28","author":"Sanders","year":"2009","journal-title":"Cornea"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/ICO.0b013e3181e2f0f3","article-title":"Comparison of Besifloxacin, Gatifloxacin, and Moxifloxacin against Strains of Pseudomonas aeruginosa with Different Quinolone Susceptibility Patterns in a Rabbit Model of Keratitis","volume":"30","author":"Sanders","year":"2011","journal-title":"Cornea"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1089\/jop.2014.0039","article-title":"Besifloxacin Ophthalmic Suspension 0.6% in the Treatment of Bacterial Keratitis: A Retrospective Safety Surveillance Study","volume":"31","author":"Schechter","year":"2015","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1167\/iovs.66.6.58","article-title":"Whole Genome Analysis of Ocular Pseudomonas aeruginosa Isolates Reveals Genetic Diversity","volume":"66","author":"Miranda","year":"2025","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_49","unstructured":"Simakurthy, S., and Tripathy, K. (2023). Endophthalmitis. StatPearls, StatPearls Publishing."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Luaces-Rodr\u00edguez, A., Gonz\u00e1lez-Barcia, M., Blanco-Teijeiro, M.J., Gil-Mart\u00ednez, M., Gonzalez, F., G\u00f3mez-Ulla, F., Lamas, M.-J., Otero-Espinar, F.-J., and Fern\u00e1ndez-Ferreiro, A. (2018). Review of Intraocular Pharmacokinetics of Anti-Infectives Commonly Used in the Treatment of Infectious Endophthalmitis. Pharmaceutics, 10.","DOI":"10.3390\/pharmaceutics10020066"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1016\/j.jcrs.2010.09.013","article-title":"Intravitreal Piperacillin\/Tazobactam in the Management of Multidrug-Resistant Pseudomonas aeruginosa Endophthalmitis","volume":"36","author":"Pathengay","year":"2010","journal-title":"J. Cataract Refract Surg."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1128\/CMR.00113-16","article-title":"Bacterial and Fungal Endophthalmitis","volume":"30","author":"Durand","year":"2017","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1001\/archopht.1991.01080070058035","article-title":"Aminoglycoside Toxicity\u2014A Survey of Retinal Specialists. Implications for Ocular Use","volume":"109","author":"Campochiaro","year":"1991","journal-title":"Arch. Ophthalmol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12348-014-0022-z","article-title":"Pharmacokinetics of Intravitreal Antibiotics in Endophthalmitis","volume":"4","author":"Radhika","year":"2014","journal-title":"J. Ophthalmic Inflamm. Infect."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/IAE.0000000000001603","article-title":"Emerging Worldwide Antimicrobial Resistance, Antibiotic Stewardship and Alternative Intravitreal Agents for the Treatment of Endophthalmitis","volume":"37","author":"Relhan","year":"2017","journal-title":"Retina"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/IAE.0b013e3181a94f01","article-title":"Intravitreal Injection of Therapeutic Agents","volume":"29","author":"Peyman","year":"2009","journal-title":"Retina"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e00070-19","DOI":"10.1128\/CMR.00070-19","article-title":"Practical Guidance for Clinical Microbiology Laboratories: Diagnosis of Ocular Infections","volume":"34","author":"Leal","year":"2021","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e00659-26","DOI":"10.1128\/mbio.00659-26","article-title":"When Culture-Based Whole-Genome Sequencing Can Change Management in Severe Ocular Bacterial Infections","volume":"17","author":"Fenniri","year":"2026","journal-title":"mBio"},{"key":"ref_59","unstructured":"United States Pharmacopeia (2023). General Chapter <797>: Pharmaceutical Compounding\u2014Sterile Preparations. United States Pharmacopeia\u2013National Formulary, United States Pharmacopeial Convention."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1097\/ICO.0000000000001992","article-title":"Stability and Sterility of Extemporaneously Prepared Nonpreserved Cefazolin, Ceftazidime, Vancomycin, Amphotericin B, and Methylprednisolone Eye Drops","volume":"38","author":"Ratprasatporn","year":"2019","journal-title":"Cornea"},{"key":"ref_61","unstructured":"Centers for Disease Control and Prevention (2021, May 11). Antibiotic Resistance: A Global Threat, Available online: https:\/\/www.cdc.gov\/drugresistance\/solutions-initiative\/stories\/ar-global-threat.Html."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s40123-021-00449-9","article-title":"A Systematic Review of Multi-Decade Antibiotic Resistance Data for Ocular Bacterial Pathogens in the United States","volume":"11","author":"Bispo","year":"2022","journal-title":"Ophthalmol. Ther."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2147\/OPTO.S189115","article-title":"Antibiotic Resistance among Ocular Pathogens: Current Trends from the ARMOR Surveillance Study (2009\u20132016)","volume":"11","author":"Thomas","year":"2019","journal-title":"Clin. Optom."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1097\/ICO.0000000000000431","article-title":"Antibiotic Resistance in the Treatment of Staphylococcus aureus Keratitis: A 20-Year Review","volume":"34","author":"Chang","year":"2015","journal-title":"Cornea"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e0124723","DOI":"10.1128\/aac.01247-23","article-title":"Characterization of the Resistome and Predominant Genetic Lineages of Gram-Positive Bacteria Causing Keratitis","volume":"68","author":"Ung","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ajo.2023.06.016","article-title":"Microbiology of Eye Infections at the Massachusetts Eye and Ear: An 8-Year Retrospective Review Combined with Genomic Epidemiology","volume":"255","author":"Lebreton","year":"2023","journal-title":"Am. J. Ophthalmol."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Manente, R., Santella, B., Pagliano, P., Santoro, E., Casolaro, V., Borrelli, A., Capunzo, M., Galdiero, M., Franci, G., and Boccia, G. (2022). Prevalence and Antimicrobial Resistance of Causative Agents to Ocular Infections. Antibiotics, 11.","DOI":"10.3390\/antibiotics11040463"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/sj.eye.6701465","article-title":"External Ocular Infections Due to Methicillin-Resistant Staphylococcus aureus (MRSA)","volume":"19","author":"Shanmuganathan","year":"2005","journal-title":"Eye"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"e00355-19","DOI":"10.1128\/AAC.00355-19","article-title":"The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program","volume":"63","author":"Diekema","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Andr\u00e9, C., and Gilmore, M.S. (2026). Epidemiologic and Clinical Divergence of MRSA USA100 and USA300 in the United States. Antibiotics, 15.","DOI":"10.3390\/antibiotics15040372"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/ICO.0b013e3181d2ce25","article-title":"In Vitro Susceptibility Patterns of Methicillin-Resistant Staphylococcus aureus and Coagulase-Negative Staphylococcus Corneal Isolates to Antibiotics","volume":"29","author":"Elsahn","year":"2010","journal-title":"Cornea"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ajo.2018.09.032","article-title":"Laboratory Results, Epidemiological Features, and Outcome Analyses of Microbial Keratitis: A 15-Year Review from Saint Louis","volume":"198","author":"Hsu","year":"2019","journal-title":"Am. J. Ophthalmol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1080\/09273948.2020.1799033","article-title":"Common Microbes and Antibiotic Resistance in Ocular Infections at an Urban Public Tertiary Care Hospital","volume":"30","author":"Geevarghese","year":"2022","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.ophtha.2014.02.001","article-title":"Microbiological Spectrum and Antibiotic Sensitivity in Endophthalmitis: A 25-Year Review","volume":"121","author":"Gentile","year":"2014","journal-title":"Ophthalmology"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s12325-012-0023-y","article-title":"Microbiological Etiology and Susceptibility of Bacterial Conjunctivitis Isolates from Clinical Trials with Ophthalmic, Twice-Daily Besifloxacin","volume":"29","author":"Haas","year":"2012","journal-title":"Adv. Ther."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jaapos.2012.12.151","article-title":"Trends in Ophthalmic Manifestations of Methicillin-Resistant Staphylococcus aureus (MRSA) in a Northern California Pediatric Population","volume":"17","author":"Amato","year":"2013","journal-title":"J. AAPOS"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00417-010-1426-6","article-title":"Shifting Trends in in Vitro Antibiotic Susceptibilities for Common Bacterial Conjunctival Isolates in the Last Decade at the New York Eye and Ear Infirmary","volume":"249","author":"Adebayo","year":"2011","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_78","first-page":"000763","article-title":"Population Structure of Ocular Streptococcus pneumoniae Is Highly Diverse and Formed by Lineages That Escape Current Vaccines","volume":"8","author":"Andre","year":"2022","journal-title":"Microb. Genom."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"ofad098","DOI":"10.1093\/ofid\/ofad098","article-title":"Trends in Streptococcus pneumoniae Antimicrobial Resistance in US Children: A Multicenter Evaluation","volume":"10","author":"Mohanty","year":"2023","journal-title":"Open Forum Infect. Dis."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"ofac420","DOI":"10.1093\/ofid\/ofac420","article-title":"A Multicenter Evaluation of Trends in Antimicrobial Resistance Among Streptococcus pneumoniae Isolates From Adults in the United States","volume":"9","author":"Mohanty","year":"2022","journal-title":"Open Forum Infect. Dis."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"104632","DOI":"10.1016\/j.idnow.2022.11.001","article-title":"French Regional Pneumococcal Observatories (ORP) network. Invasive Pneumococcal Infections in France: Changes from 2009 to 2021 in Antibiotic Resistance and Serotype Distribution of Streptococcus pneumoniae Based on Data from the French Regional Pneumococcal Observatories Network","volume":"53","author":"Plainvert","year":"2023","journal-title":"Infect. Dis. Now."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1164\/rccm.201504-0701ED","article-title":"Macrolide-Resistant Pneumococcus in Community-Acquired Pneumonia. Is There Still a Role for Macrolide Therapy?","volume":"191","author":"Niederman","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"ofab063","DOI":"10.1093\/ofid\/ofab063","article-title":"A Multicenter Evaluation of the US Prevalence and Regional Variation in Macrolide-Resistant S. pneumoniae in Ambulatory and Hospitalized Adult Patients in the United States","volume":"8","author":"Gupta","year":"2021","journal-title":"Open Forum Infect. Dis."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"101359","DOI":"10.1016\/j.lanmic.2026.101359","article-title":"Regional and Temporal Trends in Antimicrobial Susceptibility among Isolates from Bacterial Keratitis: A Systematic Review and Meta-Analysis","volume":"7","author":"Tuft","year":"2026","journal-title":"Lancet Microbe"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/ceo.14377","article-title":"Antimicrobial Resistance in Ocular Infection: A Review","volume":"52","author":"Kandel","year":"2024","journal-title":"Clin. Exp. Ophthalmol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1038\/s41433-021-01643-6","article-title":"The burden of methicillin-resistant Staphylococcus aureus in the delivery of eye care","volume":"36","author":"Harford","year":"2022","journal-title":"Eye"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Chuang, C.-C., Hsiao, C.-H., Tan, H.-Y., Ma, D.H.-K., Lin, K.-K., Chang, C.-J., and Huang, Y.-C. (2012). Staphylococcus aureus Ocular Infection: Methicillin-Resistance, Clinical Features, and Antibiotic Susceptibilities. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0042437"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Zheng, X.-Y., Choy, B.N.K., Zhou, M.-M., and Zhao, Z.-Y. (2021). Antibiotic Resistance Pattern of Staphylococcus aureus Isolated From Pediatrics with Ocular Infections: A 6-Year Hospital-Based Study in China. Front. Pediatr., 9.","DOI":"10.3389\/fped.2021.728634"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev-biochem-061809-112742","article-title":"Structural Perspective of Peptidoglycan Biosynthesis and Assembly","volume":"81","author":"Lovering","year":"2012","journal-title":"Annu. Rev. Biochem."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1073\/pnas.54.4.1133","article-title":"Mechanism of Action of Penicillins: A Proposal Based on Their Structural Similarity to Acyl-D-Alanyl-D-Alanine","volume":"54","author":"Tipper","year":"1965","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1128\/AAC.00429-15","article-title":"Commensal Streptococci Serve as a Reservoir for \u03b2-Lactam Resistance Genes in Streptococcus pneumoniae","volume":"59","author":"Jensen","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0140-6736(48)92166-7","article-title":"Infection by Penicillin-Resistant Staphylococci","volume":"2","author":"Barber","year":"1948","journal-title":"Lancet"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1046\/j.1365-2958.1997.4051770.x","article-title":"Studies of the Repressor (BlaI) of \u03b2-Lactamase Synthesis in Staphylococcus aureus","volume":"24","author":"Gregory","year":"1997","journal-title":"Mol. Microbiol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0140-6736(63)91687-8","article-title":"Methicillin Resistance in Staphylococci","volume":"1","author":"Jevons","year":"1963","journal-title":"Lancet"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/iub.1289","article-title":"Penicillin-Binding Protein 2a of Methicillin-Resistant Staphylococcus aureus","volume":"66","author":"Fishovitz","year":"2014","journal-title":"IUBMB Life"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1128\/jb.171.5.2882-2885.1989","article-title":"Expression and Inducibility in Staphylococcus aureus of the mecA Gene, Which Encodes a Methicillin-Resistant S. Aureus-Specific Penicillin-Binding Protein","volume":"171","author":"Ubukata","year":"1989","journal-title":"J. Bacteriol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1128\/AAC.44.6.1549-1555.2000","article-title":"A New Class of Genetic Element, Staphylococcus Cassette Chromosome Mec, Encodes Methicillin Resistance in Staphylococcus aureus","volume":"44","author":"Katayama","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/978-1-62703-664-1_8","article-title":"Staphylococcal Cassette Chromosome Mec (SCCmec) Analysis of MRSA","volume":"1085","author":"Ito","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"7597","DOI":"10.1128\/AAC.01692-15","article-title":"Novel Type XII Staphylococcal Cassette Chromosome Mec Harboring a New Cassette Chromosome Recombinase, CcrC2","volume":"59","author":"Wu","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.meegid.2018.03.013","article-title":"Novel SCCmec Type XIII (9A) Identified in an ST152 Methicillin-Resistant Staphylococcus aureus","volume":"61","author":"Baig","year":"2018","journal-title":"Infect. Genet Evol."},{"key":"ref_101","first-page":"46","article-title":"Novel Staphylococcal Cassette Chromosome Mec (SCCmec) Type XIV (5A) and a Truncated SCCmec Element in SCC Composite Islands Carrying speG in ST5 MRSA in Japan","volume":"75","author":"Urushibara","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/jac\/dkab500","article-title":"Novel SCCmec Type XV (7A) and Two Pseudo-SCCmec Variants in Foodborne MRSA in China","volume":"77","author":"Wang","year":"2022","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Uehara, Y. (2022). Current Status of Staphylococcal Cassette Chromosome Mec (SCCmec). Antibiotics, 11.","DOI":"10.3390\/antibiotics11010086"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"International Working Group on the Classification of Staphylococcal Cassette Chromosome Elements (IWG-SCC) (2009). Classification of Staphylococcal Cassette Chromosome Mec (SCCmec): Guidelines for Reporting Novel SCCmec Elements. Antimicrob. Agents Chemother., 53, 4961\u20134967.","DOI":"10.1128\/AAC.00579-09"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(97)07324-8","article-title":"Dissemination in Japanese Hospitals of Strains of Staphylococcus aureus Heterogeneously Resistant to Vancomycin","volume":"350","author":"Hiramatsu","year":"1997","journal-title":"Lancet"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/jac\/40.1.135","article-title":"Methicillin-Resistant Staphylococcus aureus Clinical Strain with Reduced Vancomycin Susceptibility","volume":"40","author":"Hiramatsu","year":"1997","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1046\/j.1469-0691.2001.00054.x","article-title":"The VISA\/GISA Problem: Therapeutic Implications","volume":"7","year":"2001","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1086\/346207","article-title":"Epidemiological and Microbiological Characterization of Infections Caused by Staphylococcus aureus with Reduced Susceptibility to Vancomycin, United States, 1997\u20132001","volume":"36","author":"Fridkin","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"5845","DOI":"10.1128\/AAC.01139-12","article-title":"Contribution of Selected Gene Mutations to Resistance in Clinical Isolates of Vancomycin-Intermediate Staphylococcus aureus","volume":"56","author":"Hafer","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1128\/JCM.02144-10","article-title":"Impact of rpoB Mutations on Reduced Vancomycin Susceptibility in Staphylococcus aureus","volume":"49","author":"Watanabe","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/jac\/dkp394","article-title":"Genetic Changes Associated with Glycopeptide Resistance in Staphylococcus aureus: Predominance of Amino Acid Substitutions in YvqF\/VraSR","volume":"65","author":"Kato","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1128\/CMR.00042-09","article-title":"Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications","volume":"23","author":"Howden","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1128\/JCM.00775-12","article-title":"Relationship between Vancomycin-Resistant Staphylococcus aureus, Vancomycin-Intermediate S. aureus, High Vancomycin MIC, and Outcome in Serious S. aureus Infections","volume":"50","author":"Holmes","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1126\/science.1090956","article-title":"Genetic Analysis of a High-Level Vancomycin-Resistant Isolate of Staphylococcus aureus","volume":"302","author":"Weigel","year":"2003","journal-title":"Science"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1086\/527392","article-title":"Vancomycin-Resistant Staphylococcus aureus in the United States, 2002\u20132006","volume":"46","author":"Sievert","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1128\/AAC.37.8.1563","article-title":"Genetics and Mechanisms of Glycopeptide Resistance in Enterococci","volume":"37","author":"Arthur","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1128\/AAC.01702-08","article-title":"Fitness Cost of VanA-Type Vancomycin Resistance in Methicillin-Resistant Staphylococcus aureus","volume":"53","author":"Foucault","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2174\/1874364101509010167","article-title":"Corneal Infection Therapy with Topical Bacteriophage Administration","volume":"9","author":"Fadlallah","year":"2015","journal-title":"Open Ophthalmol. J."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/nyas.12830","article-title":"Mechanisms of Drug Resistance: Quinolone Resistance","volume":"1354","author":"Hooper","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1365-2958.1994.tb00458.x","article-title":"Cloning and Primary Structure of Staphylococcus aureus DNA Topoisomerase IV: A Primary Target of Fluoroquinolones","volume":"13","author":"Ferrero","year":"1994","journal-title":"Mol. Microbiol."},{"key":"ref_121","first-page":"377","article-title":"DNA Gyrase, Topoisomerase IV, and the 4-Quinolones","volume":"61","author":"Drlica","year":"1997","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1128\/AAC.34.6.1271","article-title":"Quinolone Resistance-Determining Region in the DNA Gyrase gyrA Gene of Escherichia coli","volume":"34","author":"Yoshida","year":"1990","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1136\/bjo.2007.129858","article-title":"Mutations in the Quinolone Resistance Determining Region in Staphylococcus epidermidis Recovered from Conjunctiva and Their Association with Susceptibility to Various Fluoroquinolones","volume":"92","author":"Yamada","year":"2008","journal-title":"Br. J. Ophthalmol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1128\/JCM.00846-13","article-title":"Emerging 8-Methoxyfluoroquinolone Resistance among Methicillin-Susceptible Staphylococcus epidermidis Isolates Recovered from Patients with Endophthalmitis","volume":"51","author":"Bispo","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1128\/AAC.41.2.471","article-title":"Targeting of DNA Gyrase in Streptococcus pneumoniae by Sparfloxacin: Selective Targeting of Gyrase or Topoisomerase IV by Quinolones","volume":"41","author":"Pan","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1128\/AAC.44.8.2160-2165.2000","article-title":"Selective Targeting of Topoisomerase IV and DNA Gyrase in Staphylococcus aureus: Different Patterns of Quinolone-Induced Inhibition of DNA Synthesis","volume":"44","author":"Fournier","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1159\/000330858","article-title":"Topoisomerase Mutations That Are Associated with High-Level Resistance to Earlier Fluoroquinolones in Staphylococcus aureus Have Less Effect on the Antibacterial Activity of Besifloxacin","volume":"57","author":"Sanfilippo","year":"2011","journal-title":"Chemotherapy"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1128\/JB.183.7.2367-2371.2001","article-title":"A Mutation in the 5\u2019 Untranslated Region Increases Stability of norA mRNA, Encoding a Multidrug Resistance Transporter of Staphylococcus aureus","volume":"183","author":"Fournier","year":"2001","journal-title":"J. Bacteriol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1128\/JB.184.5.1370-1377.2002","article-title":"NorA Functions as a Multidrug Efflux Protein in Both Cytoplasmic Membrane Vesicles and Reconstituted Proteoliposomes","volume":"184","author":"Yu","year":"2002","journal-title":"J. Bacteriol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1128\/JB.187.7.2395-2405.2005","article-title":"MgrA Is a Multiple Regulator of Two New Efflux Pumps in Staphylococcus aureus","volume":"187","author":"Dunman","year":"2005","journal-title":"J. Bacteriol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1128\/AAC.50.3.1104-1107.2006","article-title":"NorC, a New Efflux Pump Regulated by MgrA of Staphylococcus aureus","volume":"50","author":"Strahilevitz","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1128\/AAC.48.3.909-917.2004","article-title":"Novel Chromosomally Encoded Multidrug Efflux Transporter MdeA in Staphylococcus aureus","volume":"48","author":"Huang","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1248\/bpb.29.554","article-title":"Gene Cloning and Characterization of SdrM, a Chromosomally-Encoded Multidrug Efflux Pump, from Staphylococcus aureus","volume":"29","author":"Yamada","year":"2006","journal-title":"Biol. Pharm. Bull."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1128\/AAC.01065-09","article-title":"Fluoroquinolone Efflux by the Plasmid-Mediated Multidrug Efflux Pump QacB Variant QacBIII in Staphylococcus aureus","volume":"54","author":"Nakaminami","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"5406","DOI":"10.1128\/AAC.00580-10","article-title":"LmrS Is a Multidrug Efflux Pump of the Major Facilitator Superfamily from Staphylococcus aureus","volume":"54","author":"Floyd","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1128\/AAC.43.1.187","article-title":"Identification of an Efflux Pump Gene, pmrA, Associated with Fluoroquinolone Resistance in Streptococcus pneumoniae","volume":"43","author":"Gill","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"7755","DOI":"10.1021\/bi300762p","article-title":"PatA and PatB Form a Functional Heterodimeric ABC Multidrug Efflux Transporter Responsible for the Resistance of Streptococcus pneumoniae to Fluoroquinolones","volume":"51","author":"Boncoeur","year":"2012","journal-title":"Biochemistry"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1128\/AAC.35.7.1267","article-title":"Bacterial Resistance to Macrolide, Lincosamide, and Streptogramin Antibiotics by Target Modification","volume":"35","author":"Leclercq","year":"1991","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrmicro3155","article-title":"Ribosome-Targeting Antibiotics and Mechanisms of Bacterial Resistance","volume":"12","author":"Wilson","year":"2014","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1128\/AAC.43.12.2823","article-title":"Nomenclature for Macrolide and Macrolide-Lincosamide-Streptogramin B Resistance Determinants","volume":"43","author":"Roberts","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/AAC.39.3.577","article-title":"Erythromycin Resistance by Ribosome Modification","volume":"39","author":"Weisblum","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1128\/JCM.41.10.4740-4744.2003","article-title":"Practical Disk Diffusion Method for Detection of Inducible Clindamycin Resistance in Staphylococcus aureus and Coagulase-Negative Staphylococci","volume":"41","author":"Fiebelkorn","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1128\/AAC.46.9.2727-2734.2002","article-title":"Resistance to Macrolides and Related Antibiotics in Streptococcus pneumoniae","volume":"46","author":"Leclercq","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/j.1365-2958.1990.tb00696.x","article-title":"Inducible Erythromycin Resistance in Staphylococci Is Encoded by a Member of the ATP-Binding Transport Super-Gene Family","volume":"4","author":"Ross","year":"1990","journal-title":"Mol. Microbiol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1099\/mic.0.000206","article-title":"Predominant Role of Msr(D) over Mef(A) in Macrolide Resistance in Streptococcus pyogenes","volume":"162","author":"Zhang","year":"2016","journal-title":"Microbiology"},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Schroeder, M.R., and Stephens, D.S. (2016). Macrolide Resistance in Streptococcus pneumoniae. Front. Cell. Infect. Microbiol., 6.","DOI":"10.3389\/fcimb.2016.00098"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1128\/AAC.49.10.4203-4209.2005","article-title":"Macrolide Efflux in Streptococcus pneumoniae Is Mediated by a Dual Efflux Pump (Mel and Mef) and Is Erythromycin Inducible","volume":"49","author":"Ambrose","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0378-1097(03)00134-4","article-title":"Characteristic Expression of Three Genes, Msr(A), Mph(C) and Erm(Y), That Confer Resistance to Macrolide Antibiotics on Staphylococcus aureus","volume":"220","author":"Matsuoka","year":"2003","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"a027029","DOI":"10.1101\/cshperspect.a027029","article-title":"Aminoglycosides: An Overview","volume":"6","author":"Krause","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1128\/JCM.39.9.3115-3121.2001","article-title":"Identification of Aminoglycoside-Modifying Enzymes by Susceptibility Testing: Epidemiology of Methicillin-Resistant Staphylococcus aureus in Japan","volume":"39","author":"Ida","year":"2001","journal-title":"J. Clin. Microbiol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1021\/cb3005116","article-title":"Aminoglycoside Antibiotics in the 21st Century","volume":"8","author":"Becker","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.drup.2010.08.003","article-title":"Aminoglycoside Modifying Enzymes","volume":"13","author":"Ramirez","year":"2010","journal-title":"Drug Resist. Updat."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/jac\/43.2.253","article-title":"The Prevalence of Aminoglycoside Resistance and Corresponding Resistance Genes in Clinical Isolates of Staphylococci from 19 European Hospitals","volume":"43","author":"Schmitz","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"3256952","DOI":"10.1155\/2017\/3256952","article-title":"Analysis of Aminoglycoside Modifying Enzyme Genes Responsible for High-Level Aminoglycoside Resistance among Enterococcal Isolates","volume":"2017","author":"Shete","year":"2017","journal-title":"J. Pathog."},{"key":"ref_155","unstructured":"Lee, K.J. (2017). FDA Warns of HORV Risk with Compounded Vancomycin, DA. Available online: https:\/\/www.aao.org\/education\/headline\/fda-warns-of-horv-risk-with-prophylactic-vancomyci."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1001\/archopht.1993.01090060016001","article-title":"Physical Incompatibility of Vancomycin and Ceftazidime for Intravitreal Injection","volume":"111","author":"Fiscella","year":"1993","journal-title":"Arch. Ophthalmol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.ophtha.2003.09.042","article-title":"Aqueous and Vitreous Penetration of Linezolid (Zyvox) after Oral Administration","volume":"111","author":"Fiscella","year":"2004","journal-title":"Ophthalmology"},{"key":"ref_158","unstructured":"(2026, April 09). DailyMed\u2014ZYVOX-Linezolid Injection, Solution ZYVOX-Linezolid Granule, for Suspension ZYVOX-Linezolid Tablet, Film Coated, Available online: https:\/\/dailymed.nlm.nih.gov\/dailymed\/lookup.cfm?setid=6e70e63b-bfd5-478d-a8ee-8ba22c9efabd."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1089\/jop.2010.0022","article-title":"Aqueous and Vitreous Penetration of Linezolid and Levofloxacin after Oral Administration","volume":"26","author":"George","year":"2010","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1167\/iovs.11-8417","article-title":"Efficacy of Intravitreal Administrations of Linezolid in an Experimental Model of S. aureus-Related Endophthalmitis","volume":"53","author":"Saleh","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"100974","DOI":"10.1016\/j.ajoc.2020.100974","article-title":"Intravitreal Linezolid in the Management of Vancomycin-Resistant Enterococcal Endophthalmitis","volume":"20","author":"Babalola","year":"2020","journal-title":"Am. J. Ophthalmol. Case Rep."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.ajo.2013.01.010","article-title":"Topical Linezolid 0.2% for the Treatment of Vancomycin-Resistant or Vancomycin-Intolerant Gram-Positive Bacterial Keratitis","volume":"155","author":"Tu","year":"2013","journal-title":"Am. J. Ophthalmol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1097\/IAE.0b013e318207d1b9","article-title":"Intravitreal Daptomycin: A Safety and Efficacy Study","volume":"31","author":"Comer","year":"2011","journal-title":"Retina"},{"key":"ref_164","unstructured":"(2026, April 09). DailyMed\u2014DAPTOMYCIN Injection, Powder, Lyophilized, for Solution, Available online: https:\/\/dailymed.nlm.nih.gov\/dailymed\/lookup.cfm?setid=6aa6300a-f59b-4260-b021-8a02cfaeabb7."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ijmm.2019.05.010","article-title":"MprF-Mediated Daptomycin Resistance","volume":"309","author":"Ernst","year":"2019","journal-title":"Int. J. Med. Microbiol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3109\/02713683.2014.941072","article-title":"Clearance of Intravitreal Daptomycin in Uveitis-Induced Rabbit Model","volume":"40","author":"Ozcimen","year":"2015","journal-title":"Curr. Eye Res."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1592\/phco.30.12.1247","article-title":"Presence of Adequate Intravitreal Concentrations of Daptomycin after Systemic Intravenous Administration in a Patient with Endogenous Endophthalmitis","volume":"30","author":"Sheridan","year":"2010","journal-title":"Pharmacotherapy"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1089\/jop.2012.0111","article-title":"Ocular Penetration of Topically Applied 1% Daptomycin in a Rabbit Model","volume":"29","author":"Sakarya","year":"2013","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1089\/jop.2013.0120","article-title":"Efficacy of Daptomycin on Experimental Methicillin-Resistant Staphylococcus aureus Keratitis in Rabbits","volume":"29","author":"Bucak","year":"2013","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1001\/archophthalmol.2011.2527","article-title":"Intravitreal Daptomycin in a Case of Bilateral Endogenous Endophthalmitis","volume":"130","author":"Buzzacco","year":"2012","journal-title":"Arch. Ophthalmol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000444046","article-title":"Intravitreal Daptomycin for Recalcitrant Postoperative Endophthalmitis","volume":"7","author":"Sim","year":"2016","journal-title":"Case Rep. Ophthalmol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/ICO.0000000000003197","article-title":"Comparative In Vitro Activity of New Lipoglycopeptides and Vancomycin Against Ocular Staphylococci and Their Toxicity on the Human Corneal Epithelium","volume":"42","author":"Islam","year":"2023","journal-title":"Cornea"},{"key":"ref_173","unstructured":"(2026, April 09). DailyMed\u2014DALVANCE-Dalbavancin Injection, Powder, for Solution, Available online: https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=4b4674d8-4d1e-4728-8465-d42ada33fa5c."},{"key":"ref_174","unstructured":"(2026, April 09). DailyMed\u2014ORBACTIV-Oritavancin Injection, Powder, Lyophilized, for Solution, Available online: https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=ff09a726-9f9b-4e30-b509-396781293220."},{"key":"ref_175","unstructured":"(2026, April 09). DailyMed\u2014VIBATIV-Telavancin Hydrochloride Injection, Powder, Lyophilized, for Solution, Available online: https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=5359b759-db7c-4672-9e8a-59c93869bd91."},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Fenniri, I., Bispo, P., and Andr\u00e9, C. (J. Antimicrob. Chemother., 2026). In Vivo Tolerability of Topical Telavancin versus Vancomycin in a Murine Ocular Model, J. Antimicrob. Chemother., in press.","DOI":"10.1093\/jac\/dkag250"},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Andr\u00e9, C., Schrank, C.L., Cheng Jaramillo, A.V., Mylonakis, E., Wuest, W.M., Gilmore, M.S., Kim, W., and Bispo, P.J.M. (2023). Antimicrobial Activity of a New Class of Synthetic Retinoid Antibiotics and Comparator Agents against Ocular Staphylococci. Front. Antibiot., 2.","DOI":"10.3389\/frabi.2023.1101450"},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Tan, F., She, P., Zhou, L., Liu, Y., Chen, L., Luo, Z., and Wu, Y. (2019). Bactericidal and Anti-Biofilm Activity of the Retinoid Compound CD437 Against Enterococcus faecalis. Front. Microbiol., 10.","DOI":"10.3389\/fmicb.2019.02301"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jgar.2024.09.001","article-title":"Synthetic Lincosamides Iboxamycin and Cresomycin Are Active against Ocular Multidrug-Resistant Methicillin-Resistant Staphylococcus aureus Carrying Erm Genes","volume":"39","author":"Wu","year":"2024","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41586-021-04045-6","article-title":"A Synthetic Antibiotic Class Overcoming Bacterial Multidrug Resistance","volume":"599","author":"Mitcheltree","year":"2021","journal-title":"Nature"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1126\/science.adk8013","article-title":"An Antibiotic Preorganized for Ribosomal Binding Overcomes Antimicrobial Resistance","volume":"383","author":"Wu","year":"2024","journal-title":"Science"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.1128\/AAC.00126-14","article-title":"Intravitreal Injection of the Chimeric Phage Endolysin Ply187 Protects Mice from Staphylococcus aureus Endophthalmitis","volume":"58","author":"Singh","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"e2407268","DOI":"10.1002\/adma.202407268","article-title":"The Guardian of Vision: Intelligent Bacteriophage-Based Eyedrops for Clinical Multidrug-Resistant Ocular Surface Infections","volume":"36","author":"Chen","year":"2024","journal-title":"Adv. Mater."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.cmi.2019.01.017","article-title":"Revisiting Systemic Treatment of Bacterial Endophthalmitis: A Review of Intravitreal Penetration of Systemic Antibiotics","volume":"25","author":"Brockhaus","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41429-024-00778-4","article-title":"Resistance to Linezolid in Staphylococcus aureus by Mutation, Modification, and Acquisition of Genes","volume":"78","author":"Yang","year":"2025","journal-title":"J. Antibiot."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.1128\/AAC.00663-10","article-title":"Structure-Activity Relationships of Diverse Oxazolidinones for Linezolid-Resistant Staphylococcus aureus Strains Possessing the Cfr Methyltransferase Gene or Ribosomal Mutations","volume":"54","author":"Locke","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_187","doi-asserted-by":"crossref","unstructured":"Kalam, M.A., Iqbal, M., Alshememry, A., Alkholief, M., and Alshamsan, A. (2022). Development and Evaluation of Chitosan Nanoparticles for Ocular Delivery of Tedizolid Phosphate. Molecules, 27.","DOI":"10.3390\/molecules27072326"},{"key":"ref_188","doi-asserted-by":"crossref","unstructured":"Alshememry, A., Alkholief, M., Abul Kalam, M., Raish, M., Ali, R., Alhudaithi, S.S., Iqbal, M., and Alshamsan, A. (2022). Perspectives of Positively Charged Nanocrystals of Tedizolid Phosphate as a Topical Ocular Application in Rabbits. Molecules, 27.","DOI":"10.3390\/molecules27144619"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"ofae517","DOI":"10.1093\/ofid\/ofae517","article-title":"Severe Optic Neuropathy Induced by Very Prolonged Tedizolid as Suppressive Therapy: Description of a Case Report and Implication for Better Assessment","volume":"11","author":"Coustilleres","year":"2024","journal-title":"Open Forum Infect. Dis."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature26157","article-title":"A New Class of Synthetic Retinoid Antibiotics Effective against Bacterial Persisters","volume":"556","author":"Kim","year":"2018","journal-title":"Nature"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/s41564-024-01705-x","article-title":"Personalized Bacteriophage Therapy Outcomes for 100 Consecutive Cases: A Multicentre, Multinational, Retrospective Observational Study","volume":"9","author":"Pirnay","year":"2024","journal-title":"Nat. Microbiol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s40123-025-01113-2","article-title":"In Vitro Activity of Bacteriophages Against Ocular Methicillin-Resistant S. aureus Isolates Collected in the US","volume":"14","author":"Medina","year":"2025","journal-title":"Ophthalmol. Ther."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"e01088-19","DOI":"10.1128\/AAC.01088-19","article-title":"Therapeutic Effects of Intravitreously Administered Bacteriophage in a Mouse Model of Endophthalmitis Caused by Vancomycin-Sensitive or -Resistant Enterococcus faecalis","volume":"63","author":"Kishimoto","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1167\/tvst.13.12.25","article-title":"Disruption of the Enterococcus faecalis-Induced Biofilm on the Intraocular Lens Using Bacteriophages","volume":"13","author":"Kishimoto","year":"2024","journal-title":"Transl. Vis. Sci. Technol."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1167\/tvst.11.4.2","article-title":"Intracameral Bacteriophage Injection as Postoperative Prophylaxis for Enterococcus faecalis-Induced Endophthalmitis after Cataract Surgery in Rabbits","volume":"11","author":"Kishimoto","year":"2022","journal-title":"Transl. Vis. Sci. Technol."},{"key":"ref_196","doi-asserted-by":"crossref","unstructured":"Kishimoto, T., Ishida, W., Nasukawa, T., Ujihara, T., Nakajima, I., Suzuki, T., Uchiyama, J., Todokoro, D., Daibata, M., and Fukushima, A. (2021). In Vitro and In Vivo Evaluation of Three Newly Isolated Bacteriophage Candidates, phiEF7H, phiEF14H1, phiEF19G, for Treatment of Enterococcus faecalis Endophthalmitis. Microorganisms, 9.","DOI":"10.3390\/microorganisms9020212"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"100193","DOI":"10.1016\/j.xops.2022.100193","article-title":"Targeted Killing of Ocular Streptococcus pneumoniae by the Phage Endolysin MSlys","volume":"2","author":"Silva","year":"2022","journal-title":"Ophthalmol. Sci."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"e00044-23","DOI":"10.1128\/msphere.00044-23","article-title":"Therapeutic Potential of Bacillus Phage Lysin PlyB in Ocular Infections","volume":"8","author":"Mursalin","year":"2023","journal-title":"mSphere"},{"key":"ref_199","doi-asserted-by":"crossref","unstructured":"Kiljunen, S., and Resch, G. (2024). Editorial: Standards in Personalized Phage Therapy: From Phage Collection to Phage Production. Front. Cell. Infect. Microbiol., 14.","DOI":"10.3389\/fcimb.2024.1376386"},{"key":"ref_200","doi-asserted-by":"crossref","unstructured":"Bretaudeau, L., Tremblais, K., Aubrit, F., Meichenin, M., and Arnaud, I. (2020). Good Manufacturing Practice (GMP) Compliance for Phage Therapy Medicinal Products. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.01161"},{"key":"ref_201","doi-asserted-by":"crossref","unstructured":"Gallina, A., Gallina, M., Cona, A., Vitulo, P., Mularoni, A., and Provenzani, A. (2026). Phage Therapy at the Crossroads Between Clinical Promise and Regulatory Challenge. Pharmaceuticals, 19.","DOI":"10.3390\/ph19010162"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3109\/09273948.2015.1020173","article-title":"Endogenous Endophthalmitis in Patients with MRSA Septicemia: A Case Series and Review of Literature","volume":"24","author":"Shenoy","year":"2016","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_203","first-page":"e22216","article-title":"Endogenous Endophthalmitis From Methicillin-Resistant Staphylococcus aureus Bacteremia Treated with Ceftaroline","volume":"14","author":"Ho","year":"2022","journal-title":"Cureus"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1128\/AAC.01201-10","article-title":"Contrasting Effects of Acidic pH on the Extracellular and Intracellular Activities of the Anti-Gram-Positive Fluoroquinolones Moxifloxacin and Delafloxacin against Staphylococcus aureus","volume":"55","author":"Lemaire","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12348-020-0200-0","article-title":"In Vitro Susceptibilities of Methicillin-Susceptible and Resistant Staphylococci to Traditional Antibiotics Compared to a Novel Fluoroquinolone","volume":"10","author":"Fan","year":"2020","journal-title":"J. Ophthalmic Inflamm. Infect."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"50476","DOI":"10.1021\/acsomega.4c07805","article-title":"Delafloxacin-Loaded Poly(d,l-Lactide-Co-Glycolide) Nanoparticles for Topical Ocular Use: In Vitro Characterization and Antimicrobial Activity","volume":"9","author":"Alshememry","year":"2024","journal-title":"ACS Omega"},{"key":"ref_207","doi-asserted-by":"crossref","unstructured":"Cosert, K.M., Kim, S., Jalilian, I., Chang, M., Gates, B.L., Pinkerton, K.E., Van Winkle, L.S., Raghunathan, V.K., Leonard, B.C., and Thomasy, S.M. (2022). Metallic Engineered Nanomaterials and Ocular Toxicity: A Current Perspective. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14050981"},{"key":"ref_208","doi-asserted-by":"crossref","unstructured":"Pedrotti, E., Bonacci, E., Kilian, R., Pagnacco, C., Fasolo, A., Anastasi, M., Manzini, G., Bosello, F., and Marchini, G. (2022). The Role of Topical Povidone-Iodine in the Management of Infectious Keratitis: A Pilot Study. J. Clin. Med., 11.","DOI":"10.3390\/jcm11030848"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"e1161","DOI":"10.31661\/gmj.v8i0.1161","article-title":"Effectiveness of Povidone-Iodine 1% Eye Drop on Streptococcus pneumoniae and Escherichia coli Induced-Keratitis in Mice","volume":"8","author":"Najafi","year":"2019","journal-title":"Galen. Med. J."},{"key":"ref_210","first-page":"CD013001","article-title":"Corneal Collagen Cross-Linking for Bacterial Infectious Keratitis","volume":"6","author":"Davis","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_211","doi-asserted-by":"crossref","unstructured":"Yang, C., Yang, J., Lu, A., Gong, J., Yang, Y., Lin, X., Li, M., and Xu, H. (2022). Nanoparticles in Ocular Applications and Their Potential Toxicity. Front. Mol. Biosci., 9.","DOI":"10.3389\/fmolb.2022.931759"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/jpids\/pix109","article-title":"Individualized Empiric Vancomycin Dosing in Neonates Using a Model-Based Approach","volume":"8","author":"Frymoyer","year":"2019","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1136\/bjophthalmol-2016-310119","article-title":"Paediatric Infectious Keratitis: A Case Series of 107 Children Presenting to a Tertiary Referral Centre","volume":"101","author":"Rossetto","year":"2017","journal-title":"Br. J. Ophthalmol."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/15\/7\/710\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T11:35:38Z","timestamp":1784720138000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/15\/7\/710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":213,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["antibiotics15070710"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics15070710","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]}}}